2018
DOI: 10.1002/jbm.b.34293
|View full text |Cite
|
Sign up to set email alerts
|

Toward zonally tailored scaffolds for osteochondral differentiation of synovial mesenchymal stem cells

Abstract: Synovium-derived mesenchymal stem cells (SMSCs) are an emerging cell source for regenerative medicine applications, including osteochondral defect (OCD) repair. However, in contrast to bone marrow MSCs, scaffold compositions which promote SMSC chondrogenesis/osteogenesis are still being identified. In the present manuscript, we examine poly(ethylene) glycol (PEG)-based scaffolds containing zonally-specific biochemical cues to guide SMSC osteochondral differentiation. Specifically, SMSCs were encapsulated in PE… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 119 publications
0
8
0
Order By: Relevance
“…To study the osteogenic capacity of SMSCs is of great value for translational medicine. As a promising seed cell, SMSCs are progressively used to promote bone healing and formation [24]. Thus, to further study the osteogenesis mechanism of SMSCs, it might be helpful to improve the osteogenic efficiency for bone regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…To study the osteogenic capacity of SMSCs is of great value for translational medicine. As a promising seed cell, SMSCs are progressively used to promote bone healing and formation [24]. Thus, to further study the osteogenesis mechanism of SMSCs, it might be helpful to improve the osteogenic efficiency for bone regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, recent studies have also been adopting combined therapy strategies, in which multiple growth factors are delivered from a single tissue-engineered scaffold [ 153 , 154 ]. Such combinatory approaches may be of particular interest for OCTE, enabling the simultaneous delivery of factors involved in both SB and AC repair [ 155 , 156 , 157 ], even though obtaining positive results with dual growth factor delivery may not be straightforward [ 158 , 159 ]. An issue behind these combined therapy approaches is the difficulty in controlling growth factor release, so as to provide therapeutic dosages in an appropriate time frame for the promotion of cell homing, differentiation, and SB/AC tissue remodelling.…”
Section: Osteochondral Tissue Engineeringmentioning
confidence: 99%
“…For triphasic scaffolds, the middle phase is treated as a discrete layer with intermediate properties between bone and cartilage. , Often, “middle-ground” levels (between bone and cartilage) of scaffold porosity, modulus, ,,, and material composition , are used to create a transition. Successful in vitro indications often show chondrocytic proliferation in a mineralized environment and expression phenotypical of hypertrophic chondrocytes, similar to that of the calcified cartilage layer. , Examples of these strategies include diverse composites (e.g., agarose with HAp, organic sol gel-coated calcium polyphosphate), , scaffold component orientations (e.g., arrayed platelike HAp), additives for osteochondral differentiation (e.g., Mg-doped wollastonite, icariin, or zinc oxide), or components that promote a proregenerative environment (e.g., strontium or copper). , …”
Section: Considerations For Osteochondral-instructive Scaffoldsmentioning
confidence: 99%